LEK PHARMACEUTICALS D.D.

LEK PHARMACEUTICALS D.D.

Company Introduction:

LEK PHARMACEUTICALS D.D. is a leading global pharmaceutical company based in Slovenia, operating as part of Sandoz, which is a division of the Novartis Group. The company specializes in the research, development, manufacturing, and marketing of high-quality generic medicines, biosimilars, and active pharmaceutical ingredients (APIs). With a long history of innovation and commitment to healthcare, Lek plays a significant role in providing accessible and affordable medicines worldwide. Its extensive portfolio covers various therapeutic areas, aiming to improve patient lives globally.

Factory or Trader:

LEK PHARMACEUTICALS D.D. is primarily a manufacturer (factory). In the context of its operations in Uzbekistan, it functions predominantly as a trader and distributor, responsible for the sales, marketing, and distribution of its globally manufactured pharmaceutical products within the Uzbek market.

LEK PHARMACEUTICALS D.D. is a Slovenian pharmaceutical company and a part of Sandoz, the generics and biosimilars division of Novartis. While Lek Pharmaceuticals D.D. itself does not operate as a standalone entity manufacturing or directly selling under its original name in Uzbekistan, products originating from Lek's development and manufacturing, as part of the wider Sandoz portfolio, are sold and distributed in Uzbekistan. These products generally cover a broad range of therapeutic areas, including but not limited to:

Anti-infectives (e.g., antibiotics, antifungals)

Cardiovascular medicines

Central Nervous System (CNS) medicines

Respiratory medicines

Gastrointestinal medicines

Oncology medicines

Biosimilars

Over-the-counter (OTC) products

Analgesics and anti-inflammatory drugs